Valsartan/Levamlodipine Maleate

缬沙坦/马来酸左旋氨氯地平

Report date: 2024/12/10 20:00:04

Base Information

Drug NameValsartan/Levamlodipine Maleate
Drug Alias NameSYH9056SYH-9056
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated L-type calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated L-type calcium channel
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes ValsartanLevamlodipine Maleate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co LtdCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A